Annual CAPEX
$1.54 M
-$280.00 K-15.34%
31 December 2023
Summary:
Heron Therapeutics annual capital expenditures is currently $1.54 million, with the most recent change of -$280.00 thousand (-15.34%) on 31 December 2023. During the last 3 years, it has fallen by -$5.27 million (-77.32%). HRTX annual CAPEX is now -83.15% below its all-time high of $9.17 million, reached on 31 December 2018.HRTX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$431.00 K
-$206.00 K-32.34%
30 September 2024
Summary:
Heron Therapeutics quarterly capital expenditures is currently $431.00 thousand, with the most recent change of -$206.00 thousand (-32.34%) on 30 September 2024. Over the past year, it has dropped by -$362.00 thousand (-45.65%). HRTX quarterly CAPEX is now -88.96% below its all-time high of $3.90 million, reached on 31 December 2019.HRTX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$1.32 M
-$362.00 K-21.55%
30 September 2024
Summary:
Heron Therapeutics TTM capital expenditures is currently $1.32 million, with the most recent change of -$362.00 thousand (-21.55%) on 30 September 2024. Over the past year, it has dropped by -$391.00 thousand (-22.88%). HRTX TTM CAPEX is now -88.27% below its all-time high of $11.23 million, reached on 30 June 2019.HRTX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRTX CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -15.3% | -45.6% | -22.9% |
| 3 y3 years | -77.3% | -71.8% | -74.3% |
| 5 y5 years | -83.2% | +141.1% | -80.4% |
HRTX CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -77.3% | at low | -71.8% | +857.8% | -74.3% | +37.1% |
| 5 y | 5 years | -83.2% | at low | -89.0% | +141.1% | -84.0% | +37.1% |
| alltime | all time | -83.2% | >+9999.0% | -89.0% | +141.1% | -88.3% | +709.6% |
Heron Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $431.00 K(-32.3%) | $1.32 M(-21.5%) |
| June 2024 | - | $637.00 K(+154.8%) | $1.68 M(+8.7%) |
| Dec 2023 | $1.54 M(-15.3%) | $250.00 K(-68.5%) | $1.54 M(-9.6%) |
| Sept 2023 | - | $793.00 K(+185.3%) | $1.71 M(+77.8%) |
| June 2023 | - | $278.00 K(+24.1%) | $961.00 K(-4.4%) |
| Mar 2023 | - | $224.00 K(-45.9%) | $1.00 M(-44.9%) |
| Dec 2022 | $1.82 M(-39.6%) | $414.00 K(+820.0%) | $1.82 M(+1.3%) |
| Sept 2022 | - | $45.00 K(-86.0%) | $1.80 M(-45.2%) |
| June 2022 | - | $322.00 K(-69.2%) | $3.29 M(+0.2%) |
| Mar 2022 | - | $1.04 M(+167.7%) | $3.28 M(+8.5%) |
| Dec 2021 | $3.02 M(-55.6%) | $390.00 K(-74.5%) | $3.02 M(-41.0%) |
| Sept 2021 | - | $1.53 M(+386.0%) | $5.13 M(+21.3%) |
| June 2021 | - | $315.00 K(-59.9%) | $4.23 M(-9.3%) |
| Mar 2021 | - | $786.00 K(-68.5%) | $4.66 M(-31.6%) |
| Dec 2020 | $6.81 M(-4.8%) | $2.49 M(+294.6%) | $6.81 M(-17.1%) |
| Sept 2020 | - | $632.00 K(-15.6%) | $8.22 M(+25.7%) |
| June 2020 | - | $749.00 K(-74.5%) | $6.54 M(-17.8%) |
| Mar 2020 | - | $2.94 M(-24.7%) | $7.96 M(+11.2%) |
| Dec 2019 | $7.15 M(-22.0%) | $3.90 M(-472.4%) | $7.15 M(+6.4%) |
| Sept 2019 | - | -$1.05 M(-148.5%) | $6.73 M(-40.1%) |
| June 2019 | - | $2.16 M(+1.3%) | $11.23 M(+8.0%) |
| Mar 2019 | - | $2.14 M(-38.5%) | $10.40 M(+13.4%) |
| Dec 2018 | $9.17 M(+259.2%) | $3.48 M(+0.5%) | $9.17 M(+34.3%) |
| Sept 2018 | - | $3.46 M(+159.2%) | $6.83 M(+102.9%) |
| June 2018 | - | $1.33 M(+47.6%) | $3.37 M(+33.7%) |
| Mar 2018 | - | $904.00 K(-20.3%) | $2.52 M(-1.3%) |
| Dec 2017 | $2.55 M(-18.6%) | $1.13 M(<-9900.0%) | $2.55 M(+21.1%) |
| Sept 2017 | - | -$5000.00(-101.0%) | $2.11 M(-20.4%) |
| June 2017 | - | $486.00 K(-48.2%) | $2.65 M(-18.2%) |
| Mar 2017 | - | $938.00 K(+36.1%) | $3.24 M(+3.3%) |
| Dec 2016 | $3.13 M(+188.7%) | $689.00 K(+28.8%) | $3.13 M(+14.0%) |
| Sept 2016 | - | $535.00 K(-50.3%) | $2.75 M(+11.5%) |
| June 2016 | - | $1.08 M(+29.1%) | $2.47 M(+54.9%) |
| Mar 2016 | - | $834.00 K(+175.2%) | $1.59 M(+46.6%) |
| Dec 2015 | $1.09 M(-24.5%) | $303.00 K(+20.2%) | $1.09 M(-39.8%) |
| Sept 2015 | - | $252.00 K(+24.1%) | $1.80 M(+10.4%) |
| June 2015 | - | $203.00 K(-38.1%) | $1.63 M(-4.4%) |
| Mar 2015 | - | $328.00 K(-67.9%) | $1.71 M(+18.8%) |
| Dec 2014 | $1.44 M(-14.7%) | $1.02 M(+1145.1%) | $1.44 M(+146.2%) |
| Sept 2014 | - | $82.00 K(-70.5%) | $584.00 K(-60.5%) |
| June 2014 | - | $278.00 K(+387.7%) | $1.48 M(+13.2%) |
| Mar 2014 | - | $57.00 K(-65.9%) | $1.31 M(-22.4%) |
| Dec 2013 | $1.69 M(+73.4%) | $167.00 K(-82.9%) | $1.69 M(-13.3%) |
| Sept 2013 | - | $977.00 K(+821.7%) | $1.94 M(+85.9%) |
| June 2013 | - | $106.00 K(-75.6%) | $1.05 M(+6.3%) |
| Mar 2013 | - | $435.00 K(+2.1%) | $984.00 K(+1.2%) |
| Dec 2012 | $972.00 K(+89.5%) | $426.00 K(+439.2%) | $972.00 K(+4.2%) |
| Sept 2012 | - | $79.00 K(+79.5%) | $933.00 K(-4.8%) |
| June 2012 | - | $44.00 K(-89.6%) | $980.00 K(+4.7%) |
| Mar 2012 | - | $423.00 K(+9.3%) | $936.00 K(+82.5%) |
| Dec 2011 | $513.00 K(+557.7%) | $387.00 K(+207.1%) | $513.00 K(+297.7%) |
| Sept 2011 | - | $126.00 K(+4100.0%) | $129.00 K(+65.4%) |
| Dec 2010 | $78.00 K(+3800.0%) | $3000.00(-95.2%) | $78.00 K(+4.0%) |
| Sept 2010 | - | $63.00 K(>+9900.0%) | $75.00 K(+525.0%) |
| June 2010 | - | $0.00(-100.0%) | $12.00 K(0.0%) |
| Mar 2010 | - | $12.00 K(>+9900.0%) | $12.00 K(+500.0%) |
| Dec 2009 | $2000.00(-99.3%) | $0.00(0.0%) | $2000.00(-77.8%) |
| Sept 2009 | - | $0.00(0.0%) | $9000.00(-25.0%) |
| June 2009 | - | $0.00(-100.0%) | $12.00 K(-82.6%) |
| Mar 2009 | - | $2000.00(-71.4%) | $69.00 K(-76.8%) |
| Dec 2008 | $298.00 K(-38.0%) | $7000.00(+133.3%) | $298.00 K(-55.1%) |
| Sept 2008 | - | $3000.00(-94.7%) | $664.00 K(-10.0%) |
| June 2008 | - | $57.00 K(-75.3%) | $738.00 K(+6.8%) |
| Mar 2008 | - | $231.00 K(-38.1%) | $691.00 K(+43.7%) |
| Dec 2007 | $481.00 K | $373.00 K(+384.4%) | $481.00 K(+132.4%) |
| Sept 2007 | - | $77.00 K(+670.0%) | $207.00 K(+27.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2007 | - | $10.00 K(-52.4%) | $163.00 K(-8.9%) |
| Mar 2007 | - | $21.00 K(-78.8%) | $179.00 K(-4.3%) |
| Dec 2006 | $187.00 K(-40.8%) | $99.00 K(+200.0%) | $187.00 K(-19.0%) |
| Sept 2006 | - | $33.00 K(+26.9%) | $231.00 K(-23.5%) |
| June 2006 | - | $26.00 K(-10.3%) | $302.00 K(-5.3%) |
| Mar 2006 | - | $29.00 K(-79.7%) | $319.00 K(+0.9%) |
| Dec 2005 | $316.00 K(+63.7%) | $143.00 K(+37.5%) | $316.00 K(+63.7%) |
| Sept 2005 | - | $104.00 K(+141.9%) | $193.00 K(+45.1%) |
| June 2005 | - | $43.00 K(+65.4%) | $133.00 K(-33.8%) |
| Mar 2005 | - | $26.00 K(+30.0%) | $201.00 K(+4.1%) |
| Dec 2004 | $193.00 K(-23.1%) | $20.00 K(-54.5%) | $193.00 K(-19.2%) |
| Sept 2004 | - | $44.00 K(-60.4%) | $239.00 K(-4.4%) |
| June 2004 | - | $111.00 K(+516.7%) | $250.00 K(+2.9%) |
| Mar 2004 | - | $18.00 K(-72.7%) | $243.00 K(-3.2%) |
| Dec 2003 | $251.00 K(-41.4%) | $66.00 K(+20.0%) | $251.00 K(+21.8%) |
| Sept 2003 | - | $55.00 K(-47.1%) | $206.00 K(-9.3%) |
| June 2003 | - | $104.00 K(+300.0%) | $227.00 K(-49.0%) |
| Mar 2003 | - | $26.00 K(+23.8%) | $445.00 K(+4.0%) |
| Dec 2002 | $428.00 K(+56.8%) | $21.00 K(-72.4%) | $428.00 K(-14.6%) |
| Sept 2002 | - | $76.00 K(-76.4%) | $501.40 K(+5.1%) |
| June 2002 | - | $322.00 K(+3477.8%) | $477.00 K(+92.0%) |
| Mar 2002 | - | $9000.00(-90.5%) | $248.50 K(-9.0%) |
| Dec 2001 | $273.00 K(+52.5%) | $94.40 K(+82.9%) | $273.00 K(+26.4%) |
| Sept 2001 | - | $51.60 K(-44.8%) | $215.90 K(-28.1%) |
| June 2001 | - | $93.50 K(+179.1%) | $300.40 K(+49.4%) |
| Mar 2001 | - | $33.50 K(-10.2%) | $201.10 K(+12.3%) |
| Dec 2000 | $179.00 K(-10.5%) | $37.30 K(-72.6%) | $179.00 K(+13.4%) |
| Sept 2000 | - | $136.10 K(-2446.6%) | $157.90 K(+2719.6%) |
| June 2000 | - | -$5800.00(-150.9%) | $5600.00(-95.0%) |
| Mar 2000 | - | $11.40 K(-29.6%) | $111.40 K(-44.3%) |
| Dec 1999 | $200.00 K(-87.5%) | $16.20 K(-200.0%) | $200.00 K(-192.5%) |
| Sept 1999 | - | -$16.20 K(-116.2%) | -$216.20 K(+8.1%) |
| June 1999 | - | $100.00 K(0.0%) | -$200.00 K(-140.0%) |
| Mar 1999 | - | $100.00 K(-125.0%) | $500.00 K(-68.8%) |
| Dec 1998 | $1.60 M(-42.9%) | -$400.00 K(<-9900.0%) | $1.60 M(-54.3%) |
| Sept 1998 | - | $0.00(-100.0%) | $3.50 M(-16.7%) |
| June 1998 | - | $800.00 K(-33.3%) | $4.20 M(+7.7%) |
| Mar 1998 | - | $1.20 M(-20.0%) | $3.90 M(+39.3%) |
| Dec 1997 | $2.80 M(+300.0%) | $1.50 M(+114.3%) | $2.80 M(+100.0%) |
| Sept 1997 | - | $700.00 K(+40.0%) | $1.40 M(+27.3%) |
| June 1997 | - | $500.00 K(+400.0%) | $1.10 M(+57.1%) |
| Mar 1997 | - | $100.00 K(0.0%) | $700.00 K(0.0%) |
| Dec 1996 | $700.00 K(-22.2%) | $100.00 K(-75.0%) | $700.00 K(-41.7%) |
| Sept 1996 | - | $400.00 K(+300.0%) | $1.20 M(+50.0%) |
| June 1996 | - | $100.00 K(0.0%) | $800.00 K(0.0%) |
| Mar 1996 | - | $100.00 K(-83.3%) | $800.00 K(-11.1%) |
| Dec 1995 | $900.00 K(+50.0%) | $600.00 K(>+9900.0%) | $900.00 K(+125.0%) |
| Sept 1995 | - | $0.00(-100.0%) | $400.00 K(-33.3%) |
| June 1995 | - | $100.00 K(-50.0%) | $600.00 K(0.0%) |
| Mar 1995 | - | $200.00 K(+100.0%) | $600.00 K(0.0%) |
| Dec 1994 | $600.00 K(-50.0%) | $100.00 K(-50.0%) | $600.00 K(-25.0%) |
| Sept 1994 | - | $200.00 K(+100.0%) | $800.00 K(-20.0%) |
| June 1994 | - | $100.00 K(-50.0%) | $1.00 M(-16.7%) |
| Mar 1994 | - | $200.00 K(-33.3%) | $1.20 M(0.0%) |
| Dec 1993 | $1.20 M(-50.0%) | $300.00 K(-25.0%) | $1.20 M(-33.3%) |
| Sept 1993 | - | $400.00 K(+33.3%) | $1.80 M(-18.2%) |
| June 1993 | - | $300.00 K(+50.0%) | $2.20 M(-12.0%) |
| Mar 1993 | - | $200.00 K(-77.8%) | $2.50 M(+4.2%) |
| Dec 1992 | $2.40 M(+2300.0%) | $900.00 K(+12.5%) | $2.40 M(+60.0%) |
| Sept 1992 | - | $800.00 K(+33.3%) | $1.50 M(+114.3%) |
| June 1992 | - | $600.00 K(+500.0%) | $700.00 K(+600.0%) |
| Mar 1992 | - | $100.00 K(>+9900.0%) | $100.00 K(-50.0%) |
| Dec 1991 | $100.00 K(-50.0%) | - | - |
| Dec 1990 | $200.00 K(-71.4%) | $0.00(-100.0%) | $200.00 K(0.0%) |
| Sept 1990 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| June 1990 | - | $100.00 K | $100.00 K |
| Dec 1989 | $700.00 K | - | - |
FAQ
- What is Heron Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Heron Therapeutics?
- What is Heron Therapeutics annual CAPEX year-on-year change?
- What is Heron Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Heron Therapeutics?
- What is Heron Therapeutics quarterly CAPEX year-on-year change?
- What is Heron Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Heron Therapeutics?
- What is Heron Therapeutics TTM CAPEX year-on-year change?
What is Heron Therapeutics annual capital expenditures?
The current annual CAPEX of HRTX is $1.54 M
What is the all time high annual CAPEX for Heron Therapeutics?
Heron Therapeutics all-time high annual capital expenditures is $9.17 M
What is Heron Therapeutics annual CAPEX year-on-year change?
Over the past year, HRTX annual capital expenditures has changed by -$280.00 K (-15.34%)
What is Heron Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of HRTX is $431.00 K
What is the all time high quarterly CAPEX for Heron Therapeutics?
Heron Therapeutics all-time high quarterly capital expenditures is $3.90 M
What is Heron Therapeutics quarterly CAPEX year-on-year change?
Over the past year, HRTX quarterly capital expenditures has changed by -$362.00 K (-45.65%)
What is Heron Therapeutics TTM capital expenditures?
The current TTM CAPEX of HRTX is $1.32 M
What is the all time high TTM CAPEX for Heron Therapeutics?
Heron Therapeutics all-time high TTM capital expenditures is $11.23 M
What is Heron Therapeutics TTM CAPEX year-on-year change?
Over the past year, HRTX TTM capital expenditures has changed by -$391.00 K (-22.88%)